Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Transitional Cell × Vitamins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 1

Interventions

pembrolizumab 23 Gemcitabine 23 Nivolumab 15 atezolizumab 14 Cisplatin 14 avelumab 12 Carboplatin 11 Docetaxel 10 enfortumab vedotin 8 Paclitaxel 7 durvalumab 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 pemigatinib 5 Specimen Handling 5 vinflunine 4 toripalimab 4 sacituzumab govitecan 4 cabozantinib 4 Taxes 4 cabazitaxel 3 Standard of Care 3 Pemetrexed 3 Injections 3 Everolimus 3 Albumin-Bound Paclitaxel 3 tislelizumab 2 sapanisertib 2 disitamab vedotin 2 Trastuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01490437 2014-09-25

PECULIAR

Asan Medical Center

Phase 2 Completed

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡